Stay updated on CB-839 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CB-839 in Solid Tumors Clinical Trial page.
Latest updates to the CB-839 in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.3.2 was added to the page and Revision: v3.2.0 was removed.SummaryDifference0.0%
- Check25 days agoChange DetectedRemoved a site-wide funding-status notice about government funding. The study details page content remains unchanged.SummaryDifference0.3%
- Check40 days agoChange DetectedScreenshots show only minor UI/label tweaks with no change to core sections such as the Brief Summary, Eligibility Criteria, Study Plan, or Locations, and the study title, conditions, and primary outcomes remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check68 days agoChange DetectedUpdate includes a critical operating-status notice and a new software version (v3.2.0), indicating updated deployment; removal of the prior version tag (v3.1.0) accompanies the upgrade.SummaryDifference4%
- Check75 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
- Check89 days agoChange DetectedThis is a minor release update: Revision changed from v3.0.1 to v3.0.2, and the Back to Top control was removed. No significant core content or critical data (pricing, time slots) appear to have changed.SummaryDifference0.2%
Stay in the know with updates to CB-839 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CB-839 in Solid Tumors Clinical Trial page.